| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'T2 Relaxation' found in 1 term [] and 19 definitions []
| previous 6 - 10 (of 20) nextResult Pages : [1] [2 3 4] | | | | Searchterm 'T2 Relaxation' was also found in the following services: | | | | |
| | |
| |
|
| | | | | | | Further Reading: | News & More:
|
|
| |
| | | | | |
| |
|
| | | | • View the DATABASE results for 'Bloch Equations' (2).
| | | | Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
( BOLD) In MRI the changes in blood oxygenation level are visible. Oxyhaemoglobin (the principal haemoglobin in arterial blood) has no substantial magnetic properties, but deoxyhaemoglobin (present in the draining veins after the oxygen has been unloaded in the tissues) is strongly paramagnetic. It can thus serve as an intrinsic paramagnetic contrast agent in appropriately performed brain MRI. The concentration and relaxation properties of deoxyhaemoglobin make it a susceptibility , e.g. T2 relaxation effective contrast agent with little effect on T1 relaxation.
During activation of the brain, the oxygen consumption of the local tissue increase by approximately 5% with that the oxygen tension will decrease. As a consequence, after a short period of time vasodilatation occurs, resulting in a local increase of blood volume and flow by 20 - 40%. The incommensurate change in local blood flow and oxygen extraction increases the local oxygen level.
By using T2 weighted gradient echo EPI sequences, which are highly susceptibility sensitive and fast enough to capture the three-dimensional nature of activated brain areas will show an increase in signal intensity as oxyhaemoglobin is diamagnetic and deoxyhaemoglobin is paramagnetic. Other MR pulse sequences, such as spoiled gradient echo pulse sequences are also used.
As the effects are subtle and of the order of 2% in 1.5 T MR imaging, sophisticated methodology, paradigms and data analysis techniques have to be used to consistently demonstrate the effect.
As the BOLD effect is due to the deoxygenated blood in the draining veins, the spatial localization of the region where there is increased blood flow resulting in decreased oxygen extraction is not as precisely defined as the morphological features in MRI. Rather there is a physiological blurring, and is estimated that the linear dimensions of the physiological spatial resolution of the BOLD phenomenon are around 3 mm at best. | | | | • View the DATABASE results for 'Blood Oxygenation Level Dependent Contrast' (6).
| | | | Further Reading: | | Basics:
|
|
News & More:
| |
| |
| | | Searchterm 'T2 Relaxation' was also found in the following services: | | | | |
| | |
| |
|
Coherent gradient echo sequences can measure the free induction decay ( FID), generated just after each excitation pulse or the echo formed prior to the next pulse. Coherent gradient echo sequences are very sensitive to magnetic field inhomogeneity.
An alternative to spoiling is to incorporate residual transverse magnetization directly into the longitudinal steady state.
These GRE sequences use a refocusing gradient in the phase encoding direction during the end module to maximize remaining transverse (xy) magnetization at the time when the next excitation is due, while the other two gradients are, in any case, balanced.
When the next excitation pulse is sent into the system with an opposed phase, it tilts the magnetization in the - a direction. As a result the z-magnetization is again partly tilted into the xy-plane, while the remaining xy-magnetization is tilted partly into the z-direction.
A fully refocused sequence with a properly selected and uniform f would yield higher signal, especially for tissues with long T2 relaxation times (high water content) so it is used in angiographic, myelographic or arthrographic examinations and is used for T2* weighting.
The repetition time for this sequence has to be short. With short TR, coherent GE is also useable for breath hold and 3D technique. If the repetition time is about 200 msec there's no difference between spoiled or unspoiled GE. T1 weighting is better with spoiled techniques.
The common types include GRASS, FISP, FAST, and FFE.
The T2* component decreases with long TR and short TE. The T1 time is controlled by flip angle. The common TR is less than 50 ms and the common TE less than 15 ms
Other types have stronger T2 dependence but lower SNR. They include SSFP, CE-FAST, PSIF, and CE-FFE-T2.
Examples of fully refocused FID sequences are TrueFISP, bFFE and bTFE. | | | | • View the DATABASE results for 'Coherent Gradient Echo' (6).
| | | | |
| | | | | |
| |
|
Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
•
Negative contrast agents (appearing predominantly dark on MRI) are small particulate aggregates often termed superparamagnetic iron oxide ( SPIO). These agents produce predominantly spin spin relaxation effects (local field inhomogeneities), which results in shorter T1 and T2 relaxation times.
SPIO's and ultrasmall superparamagnetic iron oxides ( USPIO) usually consist of a crystalline iron oxide core containing thousands of iron atoms and a shell of polymer, dextran, polyethyleneglycol, and produce very high T2 relaxivities. USPIOs smaller than 300 nm cause a substantial T1 relaxation. T2 weighted effects are predominant.
•
A special group of negative contrast agents (appearing dark on MRI) are perfluorocarbons ( perfluorochemicals), because their presence excludes the hydrogen atoms responsible for the signal in MR imaging.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide ( USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.
See also Adverse Reaction and Nephrogenic Systemic Fibrosis.
See also the related poll result: ' The development of contrast agents in MRI is' | | | | | | | | | | | • View the DATABASE results for 'Contrast Agents' (122).
| | | • View the NEWS results for 'Contrast Agents' (25).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
Brain imaging method may aid mild traumatic brain injury diagnosis Tuesday, 16 January 2024 by parkinsonsnewstoday.com | | |
A Targeted Multi-Crystalline Manganese Oxide as a Tumor-Selective Nano-Sized MRI Contrast Agent for Early and Accurate Diagnosis of Tumors Thursday, 18 January 2024 by www.dovepress.com | | |
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging Tuesday, 27 September 2022 by www.pharmacytimes.com | | |
How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol Saturday, 5 February 2022 by www.ncbi.nlm.nih.gov | | |
Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles Tuesday, 11 January 2022 by pubmed.ncbi.nlm.nih.gov | | |
Manganese enhanced MRI provides more accurate details of heart function after a heart attack Tuesday, 11 May 2021 by www.news-medical.net | | |
Gadopiclenol: positive results for Phase III clinical trials Monday, 29 March 2021 by www.pharmiweb.co | | |
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series Friday, 4 December 2020 by www.dovepress.com | | |
Polysaccharide-Core Contrast Agent as Gadolinium Alternative for Vascular MR Monday, 8 March 2021 by www.diagnosticimaging.com | | |
Water-based non-toxic MRI contrast agents Monday, 11 May 2020 by chemistrycommunity.nature.com | | |
New method to detect early-stage cancer identified by Georgia State, Emory research team Friday, 7 February 2020 by www.eurekalert.org | | |
Researchers Brighten Path for Creating New Type of MRI Contrast Agent Friday, 7 February 2020 by www.newswise.com | | |
Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents Wednesday, 15 November 2017 by www.eurekalert.org | | |
Sodium MRI May Show Biomarker for Migraine Friday, 1 December 2017 by psychcentral.com | | |
A natural boost for MRI scans Monday, 21 October 2013 by www.eurekalert.org | | |
For MRI, time is of the essence A new generation of contrast agents could make for faster and more accurate imaging Tuesday, 28 June 2011 by scienceline.org |
|
| |
| | | | |
| | | |
|
| |
| Look Ups |
| |